One of the RCTs that have addressed the anti-inflammatory properties of statins was the PRINCE (pravastatin inflammation/CRP evaluation) trial, which noted that statins were involved in the reduction of C-reactive protein (CRP) in patients suffering from cardiovascular diseases [37]. This evidence concerns the gene CRP and cardiovascular disorder.